Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-10-02
1994-11-15
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546118, A61K 3144, C07D47104
Patent
active
053648625
ABSTRACT:
This invention relates to adenosine derivatives and analogs which possess adenosine agonist activity and are useful as anti-hypertensive and anti-ischemic agents, to pharmaceutical compositions including such compounds, and to their use in treating hypertension and myocardial ischemia, and to methods and intermediates used in the preparation of such compounds.
REFERENCES:
patent: 3502649 (1970-03-01), Thiel et al.
patent: 3914415 (1975-11-01), Stein et al.
patent: 4167565 (1979-09-01), Stein et al.
patent: 4501735 (1985-02-01), Trivedi et al.
patent: 4593019 (1986-06-01), Bristol et al.
patent: 4600707 (1986-07-01), Patt
patent: 4636493 (1987-07-01), Patt
patent: 4657897 (1987-04-01), Bristol et al.
patent: 4657898 (1987-04-01), Bristol et al.
patent: 4663313 (1987-05-01), Bristol et al.
patent: 4683223 (1987-07-01), Trivedi et al.
patent: 4738954 (1988-04-01), Hamilton et al.
patent: 4843066 (1989-06-01), Yaamada et al.
patent: 4853386 (1989-08-01), Friebe et al.
patent: 4954504 (1990-09-01), Chen et al.
patent: 4968697 (1990-11-01), Hutchison
patent: 4977144 (1990-12-01), Fujimoto et al.
patent: 5032583 (1991-07-01), Evans
patent: 5043325 (1991-08-01), Olsson et al.
patent: 5063233 (1991-11-01), Chen et al.
Cristalli et al. J. Med. Chem. 31(6), 1179-83, 1988.
Baxter, et al., "Synthesis and Biological Activity of Carbocyclic Clitocine", Nucleosides and Nucleotides 10(1-3), 393-396 (1991).
Prasad, et al., "Modification for the 5' Position of Purine Nucleosides. 2, Synthesis and Some Cardiovascular Properties of", J. Med. Chem. 1980, 23, pp. 313-319.
Houston, et al., "Potential Inhibitors of S-Adenosylmethionine-Dependent Methyltransferasess, 9, 2',3'-Diaaldehyde Derivatives", J. Med. Chem. 1985, 28, pp. 471-477.
Franchetti, et al., "Synthesis of 3-Deazaclitocine[2-Amino-3-Nitro-4 (Beta-D Ribofuraanosylvaamino)pyridine]", Nucleosides & Nucleotides, 10(1-3), 543-545-1991.
Prasad, et al., "Modification of the 5' Position of Purine Nucleosides. 1. Synthesis and Biological Properties of Alkyl", J. Med. Chem., 1976, vol. 19, No. 10, pp. 1180-1186.
Cristalli, et al., "Adenosine and 2-Chloradenosine Deaza#Analoges as Adenosine receptor aagonists", Nucleosides & Nucleotides, 4(5), 625-639 (1985).
Antonini, et al, "Deaza Analogues of Adenosine as Inhibitors of Blood Platelet Aggregation", Journal of Pharmaceutical Sciences, pp. 366-368 vol. 73, No. 3, Mar. 1984.
Fink Cynthia A.
Myers Michael R.
Spada Alfred P.
Darkes Paul R.
Gupta Y. N.
Rhone-Poulenc Rorer Pharmaceuticals Inc.
Savitzky Martin F.
Shah Mukund J.
LandOfFree
Compounds having antihypertensive and anti-ischemic properties does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds having antihypertensive and anti-ischemic properties, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having antihypertensive and anti-ischemic properties will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1097961